UPC_CFI_140/2024

METHOD AND PRODUCT FOR LOCALISED OR SPATIAL DETECTION OF NUCLEIC ACID IN A TISSUE SAMPLE

VerletzungHauptverletzungsklageDusseldorf LDInfringementCase Closed

Übersicht Entscheidungen Begründung Zitate Dokumente Zeitverlauf

Parteien

Kläger

10x Genomics, Inc.

Vertreter: Tilman Müller-Stoy (Bardehle Pagenberg); Martin Drews (Bardehle Pagenberg)

Beklagte

Curio Bioscience Inc.

Vertreter: Agathe Michel-De Cazotte (Carpmaels & Ransford); Cameron Marschall (Carpmaels & Ransford)

Richter

Ronny Thomas
Berenice Thom
Andras Kupecz
Martin Schmidt

Patente

EP2697391
EP 2 697 391 B1

CPC-Codes: C12Q1/6827, C12Q1/6841, C12Q1/6837, C12Q1/6853, G01N1/30, G16B30/00, C12Q1/6816, C12N15/11, G16B50/20, C12Q1/6844, C12Q1/6876, G16B50/30…

Technologiebereich: Biotech · Genomics

Sektor: Biotechnology

Ausgang

VerletztVerletzt

Eingereicht: 26. März 2024

Erste Entscheidung: —

Sprache: English

Decision of the Düsseldorf Local Division finding that Curio Bioscience infringes EP 2 697 391 B1 owned by 10x Genomics. The court ordered: (A) cessation of the infringing acts in UPC member states; (B) recall from distribution channels; (C) permanent removal from distribution channels; (D) rendering of accounts; (E) damages for acts after 30 November 2019; (F) periodic penalty payments of up to EUR 100,000 per day. The action was dismissed in other respects. Costs: borne 30% by claimant, 70% by defendant. Value in dispute set at EUR 3,000,000; ceiling for recoverable representation costs EUR 400,000.

Im UPC-Register öffnen

Ansprüche

Streitigall

Verletztall

Hinweise: Düsseldorf LD found Curio Bioscience infringes EP2697391 (spatial nucleic acid detection); operative part grants injunction without specifying individual claim numbers, action partly dismissed.